These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6443657)

  • 21. [HLA, A, B and DR in 20 patients with multiple sclerosis].
    Burguera JA; Montoro JA; Coret F; Soler MA; Blasco R; López Arlandis J
    Arch Neurobiol (Madr); 1988; 51(5):278-81. PubMed ID: 3219022
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiple sclerosis: HLA studies in Italy.
    Conighi C
    Ital J Neurol Sci; 1987 Jun; Suppl 6():41-3. PubMed ID: 3498705
    [No Abstract]   [Full Text] [Related]  

  • 23. [HLA antigens in multiple sclerosis].
    Vymazal J; Krásenská J; Korinková P; Májský A
    Cesk Neurol Neurochir; 1980 Sep; 43(5):284-9. PubMed ID: 7418054
    [No Abstract]   [Full Text] [Related]  

  • 24. HLA antigens and antibody responses to measles and rubella viruses in multiple sclerosis.
    Ilonen J; Herva E; Reunanen M; Panelius M; Meurman O; Arstila P; Tiilikainen A
    Acta Neurol Scand; 1977 Apr; 55(4):299-309. PubMed ID: 855642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic susceptibility to multiple sclerosis.
    Visscher BR; Detels R; Dudley J; Haile RW; Malmgren RM; Terasaki PI; Park MS
    Neurology; 1979 Oct; 29(10):1354-60. PubMed ID: 573379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histocompatibility antigens (HLA) in multiple sclerosis in Iran.
    Lotfi J; Nikbin B; Derakhshan I; Aghai Z; Ala F
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):699-701. PubMed ID: 681957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA haplotypes in families with high frequency of multiple sclerosis.
    Olsson JE; Möller E; Link H
    Arch Neurol; 1976 Dec; 33(12):808-12. PubMed ID: 999543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenetic studies of multiple sclerosis patients in Caithness County, Scotland.
    Robertson P; Ward P; Brostoff J; Pack S; Festenstein H; Sacks J; Rosenberg RA; Peters E; Stenning P; Zabriskie JB
    Neuropathol Appl Neurobiol; 1980; 6(4):299-305. PubMed ID: 7413014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of 39 cases of multiple sclerosis (MS) including 2 familial cases. Leukocyte migration inhibition test in the presence of measles antigen with and without levamisole. HL-A typing (SD)].
    Hainaut J; Ribot C; Lefebvre P; Goasguen J; Piette JP
    Ann Med Interne (Paris); 1977 Oct; 128(10):767-72. PubMed ID: 931233
    [No Abstract]   [Full Text] [Related]  

  • 30. HLA antigens in multiple sclerosis.
    Thorsby E; Helgesen A; Solheim BG; Vandvik B
    J Neurol Sci; 1977 Jun; 32(2):187-93. PubMed ID: 301557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multiple sclerosis and the histocompatibility system].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):167-71. PubMed ID: 6176089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-A & HLA-B antigens in multiple sclerosis, motor neuron disease & Duchenne muscular dystrophy.
    Mehta MM; Chablani UA; Contractor NM; Bhatia HM; Singhal BS; Mondkar VP; Desai AD
    Indian J Med Res; 1986 May; 83():519-21. PubMed ID: 3733208
    [No Abstract]   [Full Text] [Related]  

  • 33. HLA antigens in multiple sclerosis in Alsace.
    Rumbach L; Tongio MM; Warter JM; Marescaux C; Grange D; Mayer S; Collard M
    Biomed Pharmacother; 1985; 39(7):385-9. PubMed ID: 3830266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA and multiple sclerosis in Italy: a review of the literature.
    La Mantia L; Illeni MT; Milanese C; Salmaggi A; Eoli M; Pellegris G; Nespolo A
    J Neurol; 1990 Nov; 237(7):441-4. PubMed ID: 2273414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HLA and multiple sclerosis].
    Govaerts A
    Pathol Biol (Paris); 1986 Jun; 34(6):738-40. PubMed ID: 2876407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The histocompatibility (HLA) antigen distribution in multiple sclerosis patients in Zimbabwe.
    Lowe RF; Moore HH; Briggs BR
    Cent Afr J Med; 1980 Nov; 26(11):234-6. PubMed ID: 7471189
    [No Abstract]   [Full Text] [Related]  

  • 37. [Histocompatibility patterns in multiple sclerosis. Findings of an epidemiological study (author's transl)].
    Poser S; Ritter G; Bauer HJ; Kuwert EK; Höher PG; Grosse-Wilde H; Hierholzer E
    Nervenarzt; 1981 Jun; 52(6):326-8. PubMed ID: 6973699
    [No Abstract]   [Full Text] [Related]  

  • 38. Measles antibody titers in multiple sclerosis patients and HLA-matched and unmatched siblings.
    Visscher BR; Sullivan CB; Detels R; Madden DL; Sever JL; Terasaki PI; Park MS; Dudley JP
    Neurology; 1981 Sep; 31(9):1142-5. PubMed ID: 6267516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA and the immune response to measles in multiple sclerosis.
    Myers LW; Ellison GW; Fewster ME; Terasaki P; Opelz G
    Neurology; 1976 Jun; 26(6 PT 2):54-5. PubMed ID: 944896
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF.
    Stendahl-Brodin L; Link H; Möller E; Norrby E
    Acta Neurol Scand; 1979 Jun; 59(6):297-308. PubMed ID: 90443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.